mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.04 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.04 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.04 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.04 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.086 |
0.04 |